Guided Therapeutics, Inc. (OTC: GTHP) produces a quick and painless testing platform based on its patented biophotonic technology that uses light at the cellular level for the early detection of disease. The company’s first product, the LuViva®Advanced Cervical Scan, is a non-invasive device used to detect cervical disease instantly. According to published reports, the technology was able to detect cervical cancer up to two years earlier than other conventional methods in a clinical trial with women at risk. For more information, visit the company’s website at www.guidedinc.com